ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,198.40
      -0.41%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.825
      0.34%
      Bitcoin
      62,607.08
      -0.39%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neurobiological Technologies (MM) (NTII)

      7. Neurobiological Technologies (MM) (NTII) News

      NTII

      Neurobiological (NTII)

      Neurobiological Technologies (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:NTII
      DateTimeSourceHeadlineSymbolCompany
      03/03/20086:30AMPR Newswire (US)Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimer's DiseaseNASDAQ:NTIINeurobiological Technologies (MM)
      02/26/20087:00AMPR Newswire (US)Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens' HNASDAQ:NTIINeurobiological Technologies (MM)
      02/25/20085:18PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      02/20/20087:00AMPR Newswire (US)Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of MemantineNASDAQ:NTIINeurobiological Technologies (MM)
      02/14/20083:11PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Amended Statement of Ownership (SC 13G/A)NASDAQ:NTIINeurobiological Technologies (MM)
      02/14/20083:10PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Amended Quarterly Report (10-Q/A)NASDAQ:NTIINeurobiological Technologies (MM)
      02/14/20081:07PMPR Newswire (US)Neurobiological Technologies Sets Date for Research and Development DayNASDAQ:NTIINeurobiological Technologies (MM)
      02/14/20088:30AMPR Newswire (US)Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.NASDAQ:NTIINeurobiological Technologies (MM)
      02/14/20088:00AMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Amended Statement of Ownership (SC 13G/A)NASDAQ:NTIINeurobiological Technologies (MM)
      02/13/20085:12PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Amended Statement of Ownership (SC 13G/A)NASDAQ:NTIINeurobiological Technologies (MM)
      02/11/20089:01AMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      02/11/20086:02AMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Quarterly Report (10-Q)NASDAQ:NTIINeurobiological Technologies (MM)
      02/11/20086:00AMPR Newswire (US)Neurobiological Technologies Reports Second Quarter Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
      02/07/20087:00AMPR Newswire (US)Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference CallNASDAQ:NTIINeurobiological Technologies (MM)
      02/05/20087:00AMPR Newswire (US)Neurobiological Technologies Sets Date for Second Quarter Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
      01/03/20085:23PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      12/21/20076:15PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      12/21/20077:00AMPR Newswire (US)Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from BoardNASDAQ:NTIINeurobiological Technologies (MM)
      12/20/20074:00PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      12/12/200711:00AMBusiness WireDutton Associates Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained in UpdatedNASDAQ:NTIINeurobiological Technologies (MM)
      12/05/20073:29PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      12/05/20077:45AMPR Newswire (US)Celtic Pharma Provides Update on XERECEPT(R) Clinical ProgramNASDAQ:NTIINeurobiological Technologies (MM)
      12/03/20077:30AMPR Newswire (US)Buck Institute and Neurobiological Technologies, Inc. Partner to Develop Treatment for Huntington's DiseaseNASDAQ:NTIINeurobiological Technologies (MM)
      11/30/20071:05PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      11/29/20074:46PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
      11/28/20076:30AMPR Newswire (US)Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.NASDAQ:NTIINeurobiological Technologies (MM)
      11/20/20074:10PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
      11/20/20077:30AMPR Newswire (US)Neurobiological Technologies Announces Compliance With Nasdaq Listing StandardsNASDAQ:NTIINeurobiological Technologies (MM)
      11/14/20072:33PMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ - Statement of Ownership (SC 13G)NASDAQ:NTIINeurobiological Technologies (MM)
      11/13/200711:22AMEdgar (US Regulatory)Neurobiological Technologies Inc /CA/ (Other) (4)NASDAQ:NTIINeurobiological Technologies (MM)
       Showing the most relevant articles for your search:NASDAQ:NTII